Secobarbital sodium (marketed by Eli Lilly and Company and subsequently by other companies as described below under the brand name Seconal) is a barbiturate derivative drug that was patented in 1934 in the US. It possesses anaesthetic anticonvulsant anxiolytic sedative and hypnotic properties. In the United Kingdom it was known as Quinalbarbitone.
This page contains content from the copyrighted Wikipedia article "Secobarbital"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
